private consumption, especially on the cost of living in the low-to-middle income consumer group. The mobile competition landscape in 3Q22 persisted at the same level as the previous quarter across all
acquisition after re-opening economy as well as from low base marketing spend last year amid COVID-19 lockdown • Admin & other expenses were Bt3,850mn, decreasing - 1.5%YoY and -4.8% QoQ mainly from cost
% yoy. EBITDA margin rose from 26% of hospital revenue in 3Q18 to 28% in 3Q19. The promising EBITDA was attributable to not only the revenue growth but also the effective cost control as mentioned above
, total revenue stood at THB 12,189 mn and net profit stood at THB 1,890 mn). However, the Company implemented the cost-effective management as planned to reduce impact to business performance. As a result
, total revenue decreased by 31.8% and net profit decreased by 65% YoY). However, the Company implemented the cost-effective management as planned to reduce impact to business performance. As a result of
/ Financing Cost) which edged up to 120x as of 31 December 2017. Debt to Equity Ratio decreased to extremely low level. Please be informed accordingly. Yours sincerely, (Mr. Wachira Wudhikulprapan) Managing
favorable EBITDA stemmed from not only the revenue growth but also the effective cost control as mentioned above. Financing Cost The financing cost increased from merely THB 0.3 million to the amount of THB
, this risk was relatively low. Interest Coverage ratio (EBITDA / Financing Cost) edged up to 350x in this quarter from 61x yoy while Debt to Equity Ratio maintained at extremely low level. Please be